BCR-ABL Minor Quantitative Test sale cost 2040 AED
BCR-ABL Major Quantitative Test sale cost 1800 AED BCR-ABL Major Quantitative Test 2,400 د.إ Original price was: 2,400 د.إ.1,800 د.إCurrent price is: 1,800 د.إ.
H9N7 and Influenza A RNA Detection Qualitative Test sale cost 1970 AED H9N7 and Influenza A RNA Detection Qualitative Test 2,320 د.إ Original price was: 2,320 د.إ.1,970 د.إCurrent price is: 1,970 د.إ.
Sale!

BCR-ABL Minor Quantitative Test

Original price was: 2,400 د.إ.Current price is: 2,040 د.إ.

-15%

The BCR-ABL Minor Quantitative Test is a specialized diagnostic procedure utilized to detect the presence and measure the quantity of the BCR-ABL fusion gene, which is a hallmark of certain types of leukemia, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). This test is crucial for the diagnosis, monitoring response to therapy, and detection of disease recurrence. It involves analyzing the patient’s blood or bone marrow samples through sophisticated molecular techniques to identify the BCR-ABL gene that results from the translocation between chromosomes 9 and 22, commonly referred to as the Philadelphia chromosome.

DNA Labs UAE offers this advanced testing service for a cost of 2040 AED. The facility is equipped with state-of-the-art technology and employs highly skilled professionals to ensure accurate and reliable results. Conducting the test at DNA Labs UAE provides patients and healthcare providers with critical information that aids in making informed decisions about the most appropriate treatment strategies, thus enhancing the chances of successful management of the disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

BCR/ABL Minor Quantitative Test

Cost: AED 2040.0

Test Details

The BCR/ABL minor quantitative test is a laboratory test used to monitor the levels of BCR/ABL fusion gene transcripts in patients with chronic myeloid leukemia (CML). CML is a type of cancer that affects the bone marrow and results in the overproduction of white blood cells.

The majority of CML cases are caused by a genetic abnormality known as the Philadelphia chromosome, which results in the fusion of the BCR and ABL genes. This fusion gene, known as BCR/ABL, produces a protein that promotes the uncontrolled growth of white blood cells.

The BCR/ABL minor quantitative test is performed using a technique called polymerase chain reaction (PCR). It measures the amount of BCR/ABL fusion gene transcripts in a patient’s blood or bone marrow sample. The test provides a quantitative result, indicating the number of BCR/ABL transcripts per a standardized amount of RNA.

Monitoring the levels of BCR/ABL fusion gene transcripts is important in the management of CML. The test can be used to assess the response to treatment and detect early signs of disease relapse. A decrease in BCR/ABL transcript levels indicates a good response to treatment, while an increase may indicate disease progression or resistance to therapy.

The BCR/ABL minor quantitative test is typically performed at regular intervals during the course of CML treatment. The results are interpreted in conjunction with other clinical and laboratory findings to guide treatment decisions.

Test Components

  • Price: AED 2040.0
  • Sample Condition: Whole Blood, Culture Cells, Bone marrow aspirations
  • Report Delivery: 3rd Working Day Email – 36 hours, On phone – 24 hours
  • Method: Real Time PCR
  • Test type: Viral
  • Doctor: Physician
  • Test Department: Genetics

Pre Test Information

Before undergoing the BCR/ABL minor quantitative test, patients need to sign a consent document and bring any clinical history of the patient for the test.

Test Name BCRABL Minor Quantitative Test
Components
Price 2040.0 AED
Sample Condition Whole Blood, Culture Cells, Bone marrow aspirations,
Report Delivery 3rd Working Day Email:-36 hours. On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forBCR/ABL Minor QuantitativeTest
Test Details

The BCR/ABL minor quantitative test is a laboratory test used to monitor the levels of BCR/ABL fusion gene transcripts in patients with chronic myeloid leukemia (CML).

CML is a type of cancer that affects the bone marrow and results in the overproduction of white blood cells. The majority of CML cases are caused by a genetic abnormality known as the Philadelphia chromosome, which results in the fusion of the BCR and ABL genes. This fusion gene, known as BCR/ABL, produces a protein that promotes the uncontrolled growth of white blood cells.

The BCR/ABL minor quantitative test is performed using a technique called polymerase chain reaction (PCR). It measures the amount of BCR/ABL fusion gene transcripts in a patient’s blood or bone marrow sample. The test provides a quantitative result, indicating the number of BCR/ABL transcripts per a standardized amount of RNA.

Monitoring the levels of BCR/ABL fusion gene transcripts is important in the management of CML. The test can be used to assess the response to treatment and detect early signs of disease relapse. A decrease in BCR/ABL transcript levels indicates a good response to treatment, while an increase may indicate disease progression or resistance to therapy.

The BCR/ABL minor quantitative test is typically performed at regular intervals during the course of CML treatment. The results are interpreted in conjunction with other clinical and laboratory findings to guide treatment decisions.

SKU: TEST-5009 Category:

Related products